Chinook Therapeutics

About:

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

Website: https://www.chinooktx.com

Top Investors: OrbiMed, Northleaf Capital Partners, Samsara BioCapital, Apple Tree Partners, Janus Henderson Investors

Description:

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science. The company focuses on developing precision medicines for kidney diseases. Its services offers utilization of novel translational platforms and patient stratification tools, and emergence of accelerated regulatory pathways based on surrogate endpoints.

Total Funding Amount:

$276M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2019-01-01

Contact Email:

info(AT)chinooktx.com

Founders:

Ross Haghighat

Number of Employees:

101-250

Last Funding Date:

2022-05-24

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai